Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06136182 · ClinicalTrials.gov registry record
Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery
A clinical trial, sponsored by Methodist Health System.
- Terminated
- Registry status
- 489
- Enrollment target
NCT06136182: Clinical Trial study, sponsored by Methodist Health System.
NCT06136182 is a clinical trial that was terminated before completion, run by Methodist Health System. The registered enrollment target is 489 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06136182 was terminated before completion, sponsored by Methodist Health System.
- TERMINATED
- Registry status
- 489 participants
- Enrollment target
Study Summary
A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix
Primary Outcome
30-day all-cause unplanned readmissions after discharge * Significant pleural effusion requiring thoracentesis within 30 days of surgery * Significant pleural effusion requiring thoracentesis within 60 days of surgery
Interventions
- PROCEDURE Pericardial Closure Using Gentrix Following Cardiac Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 489 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2026-04-08 |
Why NCT06136182 stopped before completion
NCT06136182 is an observational study that tracks outcomes without assigning an intervention. The registered 489 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pericardial Closure Using Gentrix Following Cardiac Surgery is the first listed.
NCT06136182 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06136182 about?
NCT06136182 is a clinical study titled "Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery". A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix
What is the current status of trial NCT06136182?
This trial is currently terminated. The enrollment target is 489 participants. The study started on 2023-05-12. Estimated completion is 2026-04-08.
What interventions are being tested in trial NCT06136182?
The interventions under investigation include: Pericardial Closure Using Gentrix Following Cardiac Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT06136182?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI